ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...

BOND-003 evaluated the efficacy and safety of cretostimogene grenadenorepvec, an oncolytic immunotherapy, in patients with carcinoma in situ BCG-unresponsive NMIBC.

The ongoing phase 2b SunRISe-1 study is assessing TAR-200 intravesical gemcitabine delivery in patients with BCG-unresponsive high-risk NMIBC.

Encephalitis International notes climate change leading to more vaccine-preventable diseases: Our Bureau, Bengaluru Tuesday, April 29, 2025, 17:15 Hrs [IST] Encephalitis Internati ...

A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...

Pfizer’s sasanlimab combo significantly improves event-free survival in BCG-naïve, high-risk non-muscle invasive bladder cancer: New York Tuesday, April 29, 2025, 14:00 Hrs [IS ...

Whitewater senior Reece Condon shot 75 to tie for fourth place at Monday's Big Foot Invitational held at the Majestic Oaks ...

The NZ$ Herald (from the Telegraph) has a headline Five surprising everyday medications that can help prevent dementia. This is surprising, because the general consensus is that we don’t really have ...

THE world’s most infectious disease has been detected in a senior school, according to health chiefs. Parents of pupils at ...

US-based pharmaceutical company Pfizer has reported positive results from a Phase III trial of sasanlimab and Bacillus ...

A closely watched clinical trial testing what could be the world’s first new tuberculosis vaccine in a century has hit its ...

Pfizer announced that its experimental drug sasanlimab, when combined with BCG therapy, significantly improved event-free ...